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ABSTRACT
Patent systems reforms have been recommended by a variety of interests, including the Federal
Trade Commission and the National Academies of Science and the private sector. Although calls for
radical reforms have undeniable merit, the effectiveness of the existing patent system as an
incentive to investment in innovation must be left untouched in the reform process. Unwise reforms
include awarding patent injunctions only sparingly and limiting patent damages to nominal
amounts for inventions relating to patentable combinations made of existing components. There
are, however, "three pillars" that should guide reform: (1) introduce full transparency and
objectiveness into the tests for determining patent validity; (2) create comprehensive post-issuance
patent revocation procedures; and (3) establish incentives for inventors to obtain fully valid patents
by eliminating the "inequitable conduct" defense for such valid patents. Further, the current
nineteenth-century patent examining paradigm should be changed to reflect the twenty-first
century realities. The new paradigm should demand increased patent applicant responsibility and
increased patent examiner accountability.
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INTRODUCTION

It is a singular honor to give a lecture in honor of Howard Markey. As I speak
here today, the future of the patent system is the subject of discussions involving
CEOs of major companies, university presidents, and distinguished members of
Congress. These discussions reflect the growing importance of the patent system to
the country's economy. The importance of today's patent system traces back to
Howard Markey and the transformation of the patent law that he was able to guide
as the first chief judge of the Federal Circuit. For someone who entered the patent
profession before the creation of the Federal Circuit, the transformation has been
career-changing. 1 As just one measure of this profound change, almost every major
law firm in the country today has a thriving patent practice; before Judge Markey's
work in remolding of the patent laws, almost none did.
The theme of patent law transformation that began over two decades ago with
the birth of the Federal Circuit forms a very useful predicate for today's topic on
patent reform. What motivates CEOs, university presidents, and members of
Congress to engage themselves in discussions of the patent system are calls for
another reformation of the patent law. If these calls for reform are heeded by
Congress, the changes to patent law and practice that would result could prove much
more breathtaking in their reach than the changes wrought by the Markey-led
2
Federal Circuit.
Calls for patent reforms are appearing today in leading newspapers and
magazines. Commentators have used the editorial pages of these publications to
suggest that today's patent law works erratically at best, sometimes producing
irrational, unfair and unacceptable results. Concerns are expressed that Congress
needs to act to retool a system that is now granting seemingly silly patents on things
like crust-free peanut butter sandwiches or the act of making a single click of a
* Robert A. Armitage has been senior Vice-President and general counsel for Eli Lilly and
Company since January of 2003. He is a member of the Company's policy and strategy committee.
He received his Bachelors of Arts degree in physics and math in 1970 from Albion College, masters
in physics from the University of Michigan, a Juris Doctor from the University of Michigan Law
School in 1973. Prior to Joining Lilly, Mr. Armitage was Chief Intellectual Property Counsel for the
Upjohn Company, and was also a partner in the Washington D.C office of Vincent and Elkins. He is
also a member and past president of the American Intellectual Property Law Association.
1 See, e.g., Howard T. Markey, Chief Judge U.S. Court of Customs and Patent Appeals, Needed:
A Judicial Welcome for Technology - Star Wars or Stare Decisis?, Address delivered to the Judicial
Conference of the Sixth Circuit (May 11, 1978), in 79 F.R.D. 209.
2 See, e.g., The Patent System: Today and Tomorrow: HearingBefore the S. Judiciary Comm. on
Intellectual Property, 109th Cong. (2005) (testimony of the Honorable Jon W. Dudas, Under
Secretary of Commerce for Intellectual Property and Director of the United States Patent and
Trademark Office), available at http://www.uspto.gov/web/offices/com/speeches/2005apr21.pdf
see
also Patent Reform Act of 2005, H.R. 2795, 109th Cong. (2005).
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computer mouse to make an online purchase. 3 From the vantage point of some
elements in the media, there is much that appears to be wrong with our patent laws
- and much to be fixed.
Against this outcry for reforms, allow me to begin by playing the role of
contrarian. I suspect it is the same type of role that Howard Markey himself would
seek to play if he were here today. How would a contrarian view the calls for reform?
In a few words, it would be with great caution. The contrarian would note that
before anyone should conclude that the patent system is broken, account should be
taken of the undeniable reality that much is right with today's patent laws and with
how they operate. Indeed, in macroeconomic terms, a strong case can be made that
today's patent system has never operated with greater effectiveness.
Over the past two decades, the patent system has been responsible for a vast
supply of venture capital being placed at the feet of innovators. The promise of
patent exclusivity - and the riches that may bring - has made investors willing to
4
place huge bets on technology-based start-up enterprises.
Since the enactment of the Bayh-Dole Act,5 universities have become engaged to an unprecedented degree - in the acquisition of patents and in the technology
transfer to private enterprise that those patents facilitate. Literally hundreds of
universities that formerly had no stake in the U.S. patent system are now using
patents licensed to the private sector to transform nascent technologies into
6
tomorrow's technological wonders.
Much commerce exists today in patents themselves.7 Private enterprises now
exist solely for the purpose of buying and selling rights to patented technology.
Commerce in rights to innovation appears to be thriving as never before.
The promise of exclusivity under the patent system has spawned entire new
industries that did not exist two decades ago. 8 From my own parochial viewpoint,
perhaps the most incredible achievement of today's patent system lies in the manner
in which it has fostered and sustained the biotechnology revolution. The last several
decades have been an era of relentless innovation in the life sciences. Patents
permitted investments in commercializing amazing new medicines that have saved
lives and restored health to countless millions of citizens.
Pharmaceutical and biotechnology companies must expend between one to two
billion dollars over the course of about a dozen years to bring a single new innovative
medicine to market. Once on the market, seven out of ten times, a new medicine will

'See, e.g., Patti Waldmeir, Get It Now from eBay, Hostage to the Patent Trolls, Intellectual
Property: The Auction Site Follows BlackBerry into Court in an American Battle over the
Ownership of 1deas, FINANCIAL TIMES (London), Mar. 16, 2006, at Comment and Analysis 15
(discussing the high profile BlackBerry and eBay cases).
4 See, e.g., The Patent System: Today and Tomorrow: HearingBefore the S. Judiciary Comm. on
Intellectual Property, 109th Cong. (2005) (testimony of the Honorable Jon W. Dudas, Under
Secretary of Commerce for Intellectual Property and Director of the United States Patent and
Trademark Office), available at http://www.uspto.gov/web/offices/com/speeches/2005apr21.pdf.
5 35 U.S.C. §§ 200-212 (2000); see also 37 C.F.R. § 401 (2006).
6 Council on Governmental Relations, The Bayh-Dole Act:
A Guide to the Law and
Implementing Regulations, Sept. 1999, http://www.ucop.edu/ott/bayh.html.
7 Cornell University Center for Technology, Enterprise, and Commercialization, Bayh-Dole Act,
http ://www.cctec.cornell.edu/bayh-dole.html.
8
ld.
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not pay back the cost of its research. 9 How do pharmaceutical companies sustain
themselves given such a risk-laden business model? Today, that sustenance comes
almost completely from an effective patent law, one that actually operates to deliver
exclusive rights for the biotechnology and pharmaceutical industry inventors.
Today's patent system is not broken, not in crisis, and not in need of radical
surgery in order to meet many of the essential expectations of innovators in the life
sciences.
If the patent system is left untouched, many in the biotechnology and
pharmaceutical industries can persuasively argue that the patent system will
continue to work for them, and for their partners in universities, to create an endless
treasure drove of innovative medicines. Indeed, many leaders of the pharmaceutical
and biotechnology industries would contend that the sky is the limit for improving
human life and human well-being if we just have the sense to leave our patent
system untouched. The patent-dependent success of these industries forms the best
case for leaving the existing patent law untouched and thereby avoiding the risk that
unwise reform would kill the patent system's effectiveness as its innovation engine.
Of course if all I that had to say today was that an overwhelming case can be
made to leave the patent system untouched, it would not be much of a lecture. It also
would not be the whole of the truth about the patent system. Allow me if you will, to
express what I believe to be the fuller truth of the matter. If the sky is the limit for
some patent system users, it is also an equal truth that the sky is falling for others.
In brief, these are the Dickensonian best of times and worst of times for the country's
patent system.
We should reflect for a moment on the "patent system run amuck" horror stories
that we have all read in the media. The patent system has a serious problem if in the
minds of opinion leaders in this country it appears to have a serious problem. A
strong patent system will not endure if conventional wisdom is that it is troubled and
troubling. More "crustless peanut butter sandwich" stories have and will shape the
public's impression about the patent system and the seriousness of its value to
innovation. The questioning of our patent laws by the media will build momentum
for changing the U.S. patent law, perhaps in unwise ways. It would be a fair bet that
the impact on decision makers has already reached our Supreme Court justices.
They are now voting to hear an unprecedented number of patent cases. 10 The cases
they are taking go to issues at the heart of the patent right.
We also know that some senior executives in the information technology and
financial services industries are clamoring for patent reforms.
Some in these
industries have made loud and persisting cries for the most radical of reforms to our
patent laws.11 Indeed, they sometimes speak in dire terms about the impact of
maintaining the status quo. Some in these industries have said that if we cannot

9 Neal Masia, The Cost of Developing a New Drug, U.S. DEPARTMENT OF STATE (Jan. 2006),
http://usinfo.state.gov/products/pubs/intelprp/cost.htm
("At current levels of reimbursement,
economists estimate that only about 30 percent of new medicines actually earn enough revenue
during their patented product lifecycle to cover the average upfront cost of development.").
10 Brandon L. Bartels, Heterogeneity In Supreme Court Deeision-Making: How Case-Level

Factors

Shape

Preference-Based

Behavior,

http://psweb.sbs.ohio

state.edu/grads/bartels/researcl/heterogeneity.pdf.
11 Sarah Lai Stirland, Trolling for Patents, THE SEATTLE TIMES, Nov.
http://seattletimes.nwsource.com/html/businesstechnology/2002622393-patent14.html.

14,

2005,
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reform our patent laws, the sky is not simply falling, but it will fall on some high12
technology U.S. enterprises.
But, which is it? Should we look to a limitless sky by simply having the wisdom
to leave the patent system untouched, or are we standing under a falling or fallen sky
that only radical reforms can repair? With the stark dichotomy between the limitless
sky and the falling or fallen sky, it should surprise no one that when patent lobbyists
visit Capitol Hill, they inevitably leave our legislators and their staffs perplexed.
Congressional leaders can only scratch their heads at the disparate views on the
13
patent system that they are hearing.
This country's most innovative, and therefore most IP-dependent, industries
sometimes appear hopelessly divided. They are lobbying Congress with viewpoints
on the patent system's operation that often appear irreconcilable. This division is
almost unprecedented.
When Congress hears from this country's preeminent
technology-creating industries, irrespective of industry sector, they typically come to
Capitol Hill with highly convergent interests and consonant voices on a wide range of
policy issues. The discordant messages on the patent system proclaim on the one
hand that urgent reform is needed to fix a broken patent system, but then other
industry voices contend, on the other hand, that if any reform is needed at all, it
must be reform that lea ves the patent system entirely untouched.
How can this discord exist among IP-dependent enterprises for which effective
IP protection is the legal bulwark keeping pirates and free-loading copycats at bay?
This question itself is remarkable. If we were to take away this country's IP systems,
the effects would be devastating in innovation-dependent enterprises, regardless of
industry sector. Destroy IP rights or their effective enforcement and there would be
no one remaining in the Biotechnology Industry Organization or the Business
Software Alliance, two of the leading industry groups that appear at times to have
14
members sitting on the most opposite sides of the current discord.
Congress is attempting to unravel the riddle of these rival views on patent
Several congressional hearings have been held thus far in the 109th
reform.
15
Congress. More hearings over the next couple months appear to be in the offing.
One massive bill to reform the patent laws has been dropped in the House of
Representatives. The leadership of the IP subcommittee in the U.S. Senate appears

12 Bruce D. Radin, Litigating Challenges To Business Methods/E-Commerce Patents:Lessons
Learned
from
Amazon.com
v.
Barnesandnoble.com,
Apr.
17,
2000,
http ://www.morganfinnegan.com/news/articlespublications/0072.
1" ADAM B. JAFFE & JOSH LERNER, INNOVATION AND ITS DISCONTENTS: How OUR BROKEN

PATENT SYSTEM IS ENDANGERING INNOVATION AND PROGRESS, AND WHAT TO DO ABOUT IT 20-21

(Princeton Univ. Press 2004).
1 See, e.g., Miyako Okada-Takagi, Japan/ US Comparisons ofBiotechnologyPatents, 6 EUBiOS
J.
ASIAN
&
INT'L
BIOETHICS
166-68
(1996),
available
at
http ://www.csu.edu.au/learning/eubios/EJ66/EJ66M.html.
15See OversightHearing on 'PatentHarmonization"."HearingBefore the Subeomm. on Courts,
the Internet, and Intellectual Property of the H Comm. on the Judiciary,109th Cong. (Apr. 27,
2006) (statement of Rep. Smith, Chairman, H. Subcomm. on Courts, the Internet, and Intellectual
Property) ("Today the subcommittee conducts its sixth hearing in the 109th Congress on patent
reform."),
available
at
http ://judiciary.house.gov/OverSight.aspx?ID=235,
http://boss.streamos.com/real/hjudiciary/courts/courtsO42706.smi.
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to be in the process of putting together legislation that would address issues of patent
reform. 16
With all this, which issues stand at the heart of the current discord? From a
pharmaceutical or biotechnology industry vantage point, that question has a simple
answer: remedies. Some in the pharmaceutical and biotechnology industries believe
that they are engaged in a life-and-death struggle over the question of what a valid
and infringed patent should be worth. These biotechnology and pharmaceutical
industry interests believe that they are confronting extremists, some of whom reside
in the information technology industry sector, who want to fix the patent system by
eviscerating the prospect of obtaining effective remedies under valid and infringed
patents. They believe themselves to be confronted by an adversary whose goal is
either to deny injunctions that today reliably stop ongoing infringement of valid
pharmaceutical patents or to change to the existing principles on how damages are
apportioned to assure reasonable royalties are set at a level that is adequate to
17
compensate for infringement of a valid patent.
On the first point, the extreme elements among the IT-industry reformers are
seen by some in the pharmaceutical and biotechnology industries as advocating for
more widespread judicial licensing of patents. In other words, reform means
providing the courts broader discretion to say to an adjudicated infringer of a valid
patent who wants to remain in the business of infringing the patent, "You have lost
your challenge to the patent, but you get to keep on infringing anyway!"
On the damages point, these same pharmaceutical and biotechnology companies
see the efforts to reform the law on patent damages as an unprecedented effort to
enact an entirely new principle into law forcing what is now commonly termed "prior
art subtraction." Under this new principle, the courts would be obligated to figure
out the inventive essence of the patent by subtracting away any component of an
infringing product that was already known at the time the patent was sought. For a
novel and non-obvious combination of known materials, there would be no basis for
18
awarding anything more than nominal damages.
The perceived assault on patent remedies is more than just a hypothetical
concern and the response of the pharmaceutical and biotechnology industries is no
reflexive overreaction. The ferocity of this assault is best illustrated by eBay's attack
on patent remedies in its reply brief at the Supreme Court. 19 The eBay brief
epitomizes the extremist view on how patent remedies should be disabled or at least
diminished. The brief opens with a reasoned argument that in a patent case, after
the validity and infringement of the patent has been established, there should be no
presumption of irreparable harm. 20 Such a presumption, according to eBay, is
Patent Reform Act of 2005, H.R. 2795, 109th Cong. (2005).
See Intellectual Property Owners Association, Patent Reform: Comparison Chart on Various
Bill
Versions
(revised
Apr.
6,
2006),
http://www.ipo.org/Template.cfm?Section=Patent-Reform1&CONTENTID=22028&TEMPLATE=/Co
ntentManagement/ContentDisplay.cfm.
18 Seo gone-rally Joseph Yosick, Compulsory Patent Licensingfor Effcient Use of Inventions, 5
U. ILL. L. REV. 1275, 1281-82 (2001) (illustrating examples where infringers have sought a judicial
compulsory license).
19Reply Brief of Petitioner, eBay Inc. v. MercExchange, L.L.C., No. 05-130 (U.S. Mar. 17, 2006)
available at http://www.abanet.org/publiced/preview/briefs/pdfs/05-06/05-130-Petitioners.pdf.
20 Id. at 2.
16
17
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contrary to traditional equitable principles. 21 However, the brief then offers a most
disconcerting -because it so crystallizes the extremist agenda for diminishing patent
remedies-that reads "[e]ven in an action between private individuals, it has long
been held that an injunction is to be used sparingly, and only in a clear and plain
case." 22 Instead of the current practice where ongoing infringement of a valid patent
is typically enjoined, eBay apparently contends that injunctive relief should exist
sparingly.
The pharmaceutical and biotechnology industries would offer a simple and
direct rejoinder: spare the injunction, spoil the patent system.
On issue of apportionment of damages, the most frequent example of the
problematic nature of adopting the principle of "prior art subtraction" comes from the
mouth of intellectual property counsel at one of this country's most highly regarded
IT-oriented, research-based companies. He has contended that Alexander Graham
Bell's invention of the telephone was nothing but putting together things that
already existed. 23 A speaker, a few wires, and microphone, among other components,
that were already individually well known. To determine a reasonable royalty for
someone infringing a patent on the telephone, the principle of "prior art subtraction"
would require disregarding all such components that already existed. Take away
those things that are prior art to the invention of the telephone, and there is, of
course, nothing left upon which to award damages. According to the "prior art
subtraction" principle, Mr. Bell didn't really deserve much of anything for inventing
the telephone.
Having sketched the battleground over patent remedies, it could readily be
concluded that the debate is an irreconcilable one between two polar extremes - one
side calling for radical reforms, the other calling for the patent system to be left
untouched. One might rationally ask if the truth were somewhere in the middle - or
is the honest truth that one extreme view of the need for reform is correct and the
other plain wrong.
My thesis for the remainder of this talk is two-fold. First, the truth does not lie
in the middle. In a certain fundamental sense, neither side should compromise on its
stance. Second, perhaps in defiance of all logic, in the most important sense, both
extremes have it right. This is a time for radical reform of the U.S. patent laws and
it is a time when we must leave the effectiveness of the patent system untouched.
The challenge Congress really faces today is how to radically reform the patent laws,
going after the imbalances and unfairness that the IT sector has persuasively
identified, but leave the effectiveness of the patent system untouched. Compromises,
or timid and ineffectual reforms to the patent laws, just will not suffice to redress
real concerns over the patent system and will not address the significant root causes
for the discontent.
To understand why this is not the time for half-hearted efforts at patent reform,
we need to step back and examine what has happened to our patent system over the
last five to ten decades. The United States has had a patent system for almost
twenty-two decades. To date, 108 Congresses have helped craft our current patent

21

Id. at 7.

22

Id. at 7 (quoting Rizzo v. Goode, 423 U.S. 362, 378 (1976)).
See U.S. Patent No. 174,465 (filed Feb. 14, 1876).

23
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laws. 24 The system has grown well beyond the imagination of the members of the
1790 Congress that enacted the first patent laws. Patents issue today in vastly
greater numbers than even a few decades ago. 25 A growing backlog of work for
26
patent examiners continues to lengthen the time needed to get a patent to issue.
Inventions are made today in entirely novel areas of technology and much invention
that takes place has an unprecedented level of complexity, arising in part from the
27
incorporation of diverse and interdependent technologies.
Visitors to the Old Patent Office Building, which now houses the National
Portrait Gallery, can look at how relatively simple the work of the Patent Office once
was simply by wandering through the display patent models. For the most part, 19th
century patent examination consisted of the inspection of some simple mechanical
contrivance, represented either by a patent model or a patent drawing, and then
rummaging through a set of "shoes" housing previously issued patents in order to
assure that something truly novel had been created.
Today, a factory producing either a modern biotechnology product or computer
chip is a billion dollar creation that typically incorporates an array of innovation.
Patent lawyers sometimes face an immense task to even define the various
patentable innovations arising from a complicated, interdependent system, much less
faithfully describe them in cogent patent applications.
For the intricate and
specialized technologies that spawn today's complicated patent applications, it goes
without saying that the 19th century system for examining patent applications has a
near impossible task delivering the same level of quality and thoroughness that was
possible when most of what a patent examiner needed to know could be discerned
from inspecting a physical model or drawing of a purported invention. Simply stated,
patent examiner training and the resources available to patent examiners have not
kept pace with the change in the way technology works and the way the patent
28
system works and is now used by inventors.
24

See Markman v. Westview Instruments, 517 U.S. 370, 373 (1997).
Congress first exercised this authority in 1790, when it provided for the issuance
of "letters patent," Act of Apr. 10, 1790, ch. 7, § 1, 1 Stat. 109, which, like their
modern counterparts, granted inventors 'the right to exclude others from making,
using, offering for sale, selling, or importing the patented invention,' in exchange
for full disclosure of an invention.

Id.
25 Office of Electronic Information Products Patent Technology Monitoring Division (PTMD),
U.S. Patent & Trademark Office, U.S. Patent Statistics Chart Calendar Years 1963-2004,

http://www.uspto.gov/web/offices/ac/ido/oeip/taf/us

stat.htm (last visited Apr. 18, 2006) (noting an

increase in the number of patents issued from 48,971 in 1963 to 181,302 in 2004).
26 Id. (indicating that in the early 1960s, the number of patent applications did not exceed
100,000 and that in 2004, the number of patent applications exceeded 380,000 while less than
200,000 were issued).
27

IDEAS

See FISCAL
THAT

YEAR 1998 USPTO ANNUAL REPORT: A PATENT AND TRADEMARK OFFICE REVIEW:
BECOME

VALUABLE

INNOVATIONS,

http://www.uspto.gov/web/offices/com/annual/1998/a98r-2.htm
patent applications come from high technology areas).

available

at

(noting that the largest increase in

28 Improvements Needed to Better Manage Patent Office Automation and Address Workforce
Challenges.* Testimony Before the Subcomm. on Courts, the Internet, and IntellectualProperty of

the H Comm. on the Judiciary,109th Cong. 3 (Sept. 8, 2005) (statement of Ann K. Mittal, Directory
Science and Technology Issues and Linda D. Koontz, Director Information Management Issues),
available at http://www.gao.gov/new.items/d051008t.pdf.
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The undeniable consequence is that more patents of questionable merit now
issue. 29 We also know that the sheer volume of questionable patents has grown
because the volume of patenting today is enormous. When existence of questionable
patents reaches a "critical mass" surrounding any industry or technology, it creates a
profound impact on the freedom of action needed to implement cutting-edge
technology. 30 It is one level of concern for a business to confront an occasional patent
of questionable merit; it quite another to face a hoard of such patents and hope to
successfully surmount them all. Because of differences in the absolute number of
potentially relevant patents issuing in various technology sectors, the issue of
inadequate patent quality hits some industries quite differently from others.
An industry-relevant analogy may help illustrate how absolute numbers of
issuing patents causes the patent system to operate differently in different industry
sectors. Among information technology companies, an individual patent is often like
an individual fire ant. A typically sized IT company attempts to arm itself for battle
against its innovative competitors by amassing fire ant-like patents in the thousands.
Indeed, for such an IT company, issuing more than 1000 patents in a year is not
uncommon. If you have amassed enough "fire ant" patents, you are prepared to
battle a competitor-foe of almost any size.
In the pharmaceutical industry, the absolute number of patents issued to a
typically sized company is typically an order of magnitude less. Most patents are
sought for products that never make it to market, cutting the effective size of the
patent portfolio down by another order of magnitude. In terms of patents that stand
in the path of a generic pharmaceutical competitor seeking to market an outright
copy of an innovative medicine, the effective size of the patent portfolio of most
pharmaceutical companies is reduced by yet another order of magnitude.
What this means is that the patents that turn out to be commercially
meaningful are very few in number, sometimes only a solitary relevant patent exists.
Such solitary patents need to function like a gorilla in terms of their strength and
effectiveness in terms of standing in the way of a generic copycat.
Allow me to take a close-to-home example. My company is in the midst of a
patent struggle over a four-billion-dollar-a-year product. The FDA laws force us to
list the relevant patents on the drug standing in the way of a generic pharmaceutical
company. We have only a single relevant patent listed with the FDA. It has proven,
however, to be one gorilla-sized patent that is successfully keeping several generic
drug manufacturers off the market and will for the remainder of this decade and
beyond. If the patent system operated so that pharmaceutical industry patents of
this type could never have a size or strength bigger than that of a fire ant - such that
the generic drug companies could evade the few such patents protecting any
innovative medicine - my company would go out of business altogether.

29

Office of Audits, PTO Audits Division, U.S. Dep't of Commerce Office of Inspector General,

Patent and Trademark Office Patent Quality Controls Are Inadequate,Audit Report No. PTD-9977-

7-0001, at 3 (Sept. 1997), available at http://www.oig.doc.gov/oig/reports/1997/USPTO-PTD-9977-7
09-1997.pdf.
30 Wendy H. Schacht & John R. Thomas, Patent Reform: Innovation Issues, CRS Report for
Congress, at 6-7 (July 15, 2005), available at http://patentlaw.typepad.com/patent/RL32996.pdf
(highlighting the main arguments concerning the deleterious effect of low-quality patents).
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The flip side of this analogy is equally frightening to an IT company. A complex
IT system may have 100 patented innovations - sometimes even more - incorporated
into the system. While an IT company might be able to successfully handle one or
even a few "fire ant" patents that could stand in the path to commercialization of
such a system, it dreads the prospect that one or two gorilla-sized patents might bar
the path forward to commercialization.
When a patent of questionable merit cannot be effectively challenged in the
courts or back in the patent office, it is effectively transformed from fire ant to
gorilla. Patent quality and civil justice are critical to the IT industry to prevent such
a transformation - even for a small number of patents.
When a valid and infringed gorilla-sized patent cannot be effectively enforced in
the courts, it is transformed to a commercial weapon that is no more potent a weapon
than a solitary fire ant. Predictable enforcement of valid is a like civil justice issue
for patent owners.
What does this analogy mean to patent reform? The fight over patent remedies
can be viewed as an attempt by the IT industry to assure that questionable patents
that cannot be effectively challenged can never grow to the size and strength of a
gorilla and the response of the pharmaceutical industry can be viewed as an effort to
assure that the handful of gorilla-sized patents on which it depends for its survival
do not get transformed through patent reform into a tiny tribe of fire ants. For both
sides in the patent reform debate, the common issues are patent quality and civil
justice. Valid patents need assured enforcement with substantial and predictable
consequences meted out on infringers.
Questionable patents require legal means for effectively testing their validity
and effectively weeding out the unworthy ones. If the threat of enormous patent
damages, including the threat of punitive damages, is coupled with ineffective
opportunities to demonstrate patent invalidity, an accused infringer faces the same
type of civil justice issues that bedevil other areas of civil litigation. 31 Being forced to
settle because there is little prospect for a fair fight against a patent of questionable
validity is the antithesis of a fair and balanced patent system.
Civil justice reforms that assure questionable patents can be challenged
effectively is not inconsistent with the goal of biotechnology and pharmaceutical
industry interests that want patents to be enforceable just like other forms of
property rights. When someone is engaged in an ongoing trespass of a property, the
remedy - as a general principle - should be eviction and damages sufficient to make
the property owner whole with respect to the losses arising from the trespass.
The patent owner today faces civil justice issues that are just as problematic as
the concerns raised by the patent challenger. No system of property rights survives
if the cost of procuring and enforcing those rights exceeds the underlying value of the

'31See Blandy v. Griffith, 3 F. Cas. 675, 679 (S.D. Ohio, 1869) (The court held that the rights
secured by patent were real and should not be overthrown where there existed reasonable solutions
in favor of their validity. In particular, the court noted, "[t]his principle should be steadily borne in
mind by those to whom is entrusted the administration of civil justice."); see also Johns Hopkins
Univ. v. Cellpro, 978 F. Supp. 184, 196 (D. Del, 1997) (wherein the court at the same time
commented on its inability to bring the matter to a swift determination and awarded treble damages
for the deliberate and bad-faith infringement of the patent in question).
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property. Sadly, many patents that issue today are effectively unenforceable because
the cost of enforcement exceeds that economic value.
Patent owners and patent challengers alike have a common interest in certainty
and predictability of a patent system that ought to represent a common objective for
reform. If a patent is to operate like any other property right in terms of value for its
owner and respect by a could-be trespasser, it had better be reasonably clear to a
potential trespasser where the metes and bounds of those rights lie. If a patent law
is no more predictable than a flip of a coin on the dispositive issues of validity,
infringement and enforceability, for whom is the patent system an incentive to invest
and in what way does it serve those seeking to respect valid patent rights of others?
As just one example, claim construction reversals at the Federal Circuit, after a trial
court has thoroughly considered all of the issues is said by some to approach fifty
32
percent, almost that same as the proverbial coin toss.
Civil justice for patent litigants requires a patent system that functions as an
effective property rights system - with mechanisms for cost-effective, prompt, and
final determinations of what the valid scope of the property rights are, as well as
predictability and certainty in enforcing such valid rights.
There is one final dimension to the debate over the type of reforms that would be
wise for U.S. interests. That is the "flat world" issue. When we debate domestically
the question of whether the United States grant injunctions in patent cases only
sparingly or when we discuss whether or not, for civilization-changing inventions like
the telephone, "prior art subtraction" should limit an inventor to nominal damages,
the remainder of the world is both watching and listening. We are one of 150
countries in the World Trade Organization bound by the TRIPs agreement to observe
a set of minimum standards for IP protection. 33 What we do in the United States
with our IP laws, will not go unnoticed in the 149 other WTO countries. Many of
these countries are not inherently inclined to provide strong and effective protection
34
for patent rights.
What might our global IP village look like if we make extremist reforms to our
patent law that dilute or diminish remedies for infringing a valid patent? Imagine
for a moment that in many countries patent and copyright infringement, as well as

32

See Cybor Corp. v. FAS Techs., Inc., 138 F.3d 1448, 1476 (Fed. Cir. 1998) (Radar, J.,

dissenting) ("Nonetheless, one study shows
that the plenary standard of review has produced
reversal, in whole or in part, of almost 40% of all claim constructions since Markman I.").
33See Agreement on Trade-Related Aspects of Intellectual Property Rights, Apr. 15, 1994,
Marrakesh Agreement Establishing the World Trade Organization, Annex IC, LEGAL
INSTRUMENTS-RESULTS OF THE URUGUAY ROUND vol. 31, 33 I.L.M. 81 (1994) (setting minimal
standards of protection of intellectual property rights to be recognized by all Member countries of
the WTO).
34 See, e.g., Nermien AI-Ali, The Egyptian Pharmaceutical Industry After TRIPs. A
Praetitioner' View, 26 FORDHAM INT'L L.J. 274, 282 (2003).
In addition to the high levels of poverty and the weak infrastructures, developing
countries needed to reform their legal systems to provide adequate patent
protection for pharmaceuticals. Since the developing countries had denied patent
protection to pharmaceuticals for so long, their legal systems lacked the requisite
financial resources and knowledge to handle patent applications relating to
pharmaceuticals.
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trade secret misappropriation, was only enjoined sparingly. Imagine damages were
constrained by principles such as "prior art subtraction."
Take the hypothetical example of a product that is trademarked "Doors" that is
sold as a computer operating system sold by a very successful high-tech firm "X?"
Let's suppose that in some far-off land, a pirate company "P" has copied Doors in
order to sell its own version of Doors. It makes a colorable claim that its product is
an improvement on Doors because it has added a few modest features that meet
consumer needs in its home country, "TW."
Pirate P's arguably improved version of Doors obviously infringes both patent
and copyrights of firm X in country TW, but in country TW the extremist views of the
law on both damages and injunction applies. These remedies are only granted
sparingly, certainly not in the case where the pirate P has some improved features
they claim to have added to Doors. Additionally, any damages for ongoing
infringement of firm X's IP rights must subtract away all technology that was
previously known. So, when the courts of country TW are finished, it is decided that
for only a few yuans per copy, pirate P gets the right to continue supplying the
domestic market for Doors in country TW.
This vision of IP systems without effective remedies is not survivable for
anybody in the innovation-dependent industries. However, as we ponder how we
make needed changes to our patent law, it is absolutely critical, that we look all
across our global IP village and take account of not just what our domestic patent
reforms would mean if they were globalized, but what precedents such reforms would
set for all systems of IP protection.
If there is a case for patent reform across industry sectors based in large
measure on increasing patent quality and advancing civil justice, there is much we
can learn from recent patent litigation about type of specific reforms that are needed.
Three recent patent cases demonstrate that discontent over the current patent laws
is in no way industry-specific.
The first of these three cases forced millions of Americans, members of Congress
included, to contemplate the near unthinkable: life without a BlackBerry. 35 The
maker of the BlackBerry had what appeared to be a full and complete opportunity to
litigate to a final judgment the validity of a collection of patents, and it was found to
be an infringer of valid patents.36 It then settled the case for six-hundred million
dollars, what the patent owner likely alleged was a mere a drop in the bucket given
the supposed profits that had been reaped from the infringement. 37 But, wait a
minute. What is the real story behind those patents and their legal merit? As the
$600,000,000.00 check was being cashed by the patent owner, the United States
Patent and Trademark Office was in (and remains today in) the process of possibly
canceling those patents in a reexamination. 38 Which is it, truly valid patents or

'3
36

37

See, e.g., NTP, Inc. v. Research in Motion, Ltd., 418 F.3d 1282 (Fed. Cir. 2005).
See NTP, Inc. v. Research in Motion, Ltd., 397 F. Supp. 2d 785, 786 (E.D. VA 2005).

See Mike Hughlett, BlackBerry Suit Settled, $612.5 Million Deal Keeps Network Active,

CHI. TRIBUNE, Mar. 4, 2006, at CI; Inquirer Staff, Blackberry Way Turns Profit Into Loss, THE
INQUIRER, Apr. 6, 2005, available athttp://www.theinquirer.net/?article=22369.
38
See
Posting
of
Dennis
Crouch
to
Patently-O:
Patent
Law
Blog,
http://patentlaw.typepad.com/patent/2006/03/the war is over.html (Mar. 6, 2006).
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worthless paper? An accused infringer should not be forced to pay six-hundred
million dollars with that fundamental question remaining undecided.
A second perverse patent case is still ongoing and it demonstrates that patent
owners are being shortchanged in the civil justice department in a manner similar to
patent challengers. This case involves a valid and infringed patent owned by Purdue
Pharma. 39 In pharmaceutical industry terms, the Purdue Pharma patent was a
gorilla-sized patent, covering its top selling product, OxyContin and the only patent
40
standing in the path of another company seeking to come to market.
The Federal Circuit affirmed a lower court ruling that Purdue Pharma's
OxyContin patent was unenforceable. Purdue Pharma had allegedly engaged in
inequitable conduct. The company responded to this decision by laying off 825
employees. 41 This amounted to thirty-eight percent of its workforce because this one
42
gorilla-sized patent was taken down and exclusivity lost on its leading product.
What happened several months after this devastating court loss? The Federal
Circuit issued another opinion on reconsideration. This time the court said, in effect,
"never mind," it may all have been a big mistake. 43 On second thought the Federal
Circuit saw nothing in the record of any intent to deceive or mislead the patent
examiner. The patent did not appear to be unenforceable after all and it sent the
44
case back to the District Court to decide what to do with it.
This is clearly not how a property rights system ought to work. There are 825
employees who must be similarly convinced that this is not how a system of
intellectual property rights ought to work. Purdue Pharma shareholders fall into the
category of disbelievers that what happened here is justice.
The Purdue Pharma case is not an isolated example of the "inequitable conduct"
doctrine running amuck. In a third case, Aventis, another pharmaceutical company,
lost a patent to inequitable conduct because it filed a declaration of a world-renowned
expert to explain what a word that is commonly used and universally understood in
the pharmaceutical science actually means. The expert opined that "peroral" means
what essentially every dictionary says that it means. 45 However, the Federal Circuit
found this patent unenforceable 46 because the declarant, its world-renowned expert,
who stands accused of doing nothing more than being truthful, failed to tell the
47
patent examiner that he had a consulting relationship for the company.
The court found inequitable conduct under what appears to be a new duty of
candor, applying a "might-have-been-asked, should-have-been-answered" standard,
3 See Purdue Pharma L.P. v. Endo Pharms., Inc., 410 F.3d 690 (Fed. Cir. 2005), vacated,
Purdue Pharma L.P. v. Endo Pharms., Inc., 438 F.3d 1123, 1137 (Fed. Cir. 2006) (vacating and
remanding the judgment regarding finding of inequitable conduct).
40 See John Christoffersen, Purdue Pharma to Lay Off 825 Employees, ABCNEWS, July 1, 2005,
http://abcnews.go.com/Business/wireStory?id=900621&CMP=OTC-RSSFeeds0312.
41Id.

42 Id.
43 Purdue Pharma L.P. v. Endo Pharms., Inc., 438 F.3d 1123, 1137 (Fed. Cir. 2006) (vacating
and remanding the judgment regarding finding of inequitable conduct).
44Id.
45 Ferring B.V. v. Barr Labs., Inc., 437 F.3d 1181, 1184 (2006); see also THE AMERICAN
HERITAGE DICTIONARY OF THE ENGLISH LANGUAGE 1309 (4th ed. 2000) ("peroral: through or by way
of the mouth").
46Forring,437 F.3d at 1195.
47Id. at 1194.
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for deciding what must be told to a patent examiner. In both the Purdue Pharma
and Aventis cases, what pharmaceutical company would ever have invested in the
innovative medicines covered by these patents if it knew in advance that its
exclusivity would likely be shattered, even though the patents appeared to be fully
valid and unquestionablyinfringed?
The case for making radical reform to the patent laws and the case for leaving
the patent system as an effective incentive for innovation untouched are equally
strong. Having reconciled these two premised and exemplified some of the patent
quality and civil justice issues, what exactly should be done by Congress?
First of all, patent law must be made simple, objective and transparent. We
have too much complexity in our patent law in part because we have too many issues
in our patent law. We have either the blessing or the curse of 108 Congresses before
the present one crafting and embellishing our current patent system with all manner
of principles and doctrines. As time has gone on, we have attempted to reform our
patent laws by adding new things to it, most recently the 1952 addition of a "best
mode" requirement for disclosure. More than 200 years of judicial decisions have
afforded the courts the opportunity to engraft new doctrines onto patent law and
48
then refine and nuance them.
For these and other reasons, we have today the most non-transparent patent
system anywhere in the world. Non-public information by the bucketload can be
relevant and is sometimes dispositive to determining the true patentability of any
invention. Any patent that is picked up today, no matter how adequate the
disclosure of the invention appears to be or how complete the identification of the
relevant prior art appears to be, it cannot be known with certainty that the patent
has an adequate disclosure or that the prior art has been fully identified.
The United States wins the prize for the world's most subjective patent system.
Patent validity depends upon knowing what certain individuals thought and when
they had those contemplations, what certain individuals did in secret and when those
secret actions took place, and what subjective beliefs were formed and when. These
occult issues must be addressed in order to decide not only which side will win in a
patent case, but also how much an infringer may be assessed in damages. Unlike the
patent law in most countries outside the United States, a person skilled in the
technology and with an understanding of the patent law cannot pick up a patent
today, reference only publicly accessible information, and come to a final and
complete assessment of whether or not a patent is valid.
Most importantly, today we have a patent system that not only examining
patents too slowly, but the pace of patent examination is continuing to decelerate.
Patent examination today is a nineteenth-century creation that is fundamentally
unchanged from the way it was conducted in the nineteenth century, including how
rapidly patent applications proceed through the patent examination process and the
lack of any meaningful way for the public to participate in this process, especially
where clear-cut mistakes have been or are being made by the patent examiner.
How do we know these root causes are real causes of distress over the operation
of the patent system? We can now reference a legion of careful studies and analyses
of root causes of discontent over the patent system and proposed solutions. An
48 See Jason 0. Watson, A History of the United States Patent Office, Apr. 17, 2001,
http://www.m-cam.com/-watsonj/usptohistory.html.
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October, 2003 FTC report affirmed the need to maintain a strong patent system, but
supported making radical reforms. 49 The same can be said of the National Academy
of Sciences that issued a report a few months later, following its several-year study of
the patent system.5 0 The American Bar Association's Intellectual Property Law
Association Section, which for many years was seen by some as a more a defender of
the status quo than a bastion of support for significant patent reforms, has now
issued a sixty-four page white paper, available on its website, that explains the need
for radical surgery on our patent laws. 51 During 2003 and 2004, the American
Intellectual Property Law Association, guided by the work of a blue ribbon
committee, its Special Committee on Patent Legislative Strategies, came to a very
similar set of conclusions.
Each of these four efforts reflected serious and intensive studies of the patent
system. AIPLA's Special Committee on Patent Legislative Strategies, for example,
proposed making our system more transparent and objective through comprehensive
reforms. 52 Its proposed reforms included (1) first-inventor-to-file reforms that limit
prior art to publicly accessible art; (2) eliminating the best mode requirement to
disclose certain of the inventor's subject contemplations; (3) removing the secret prior
use exception that can invalidate a patent if the secret prior use was done
domestically, but leave the same patent valid if same work was done outside the
53
United States; and (4) eliminating subjective elements from most patent litigation.
In other words, if an issue of validity, enforceability or willfulness of an infringement
of a patent references an individual's state of mind or information not accessible to
the public, it is pushed out of the patent law - or at least to the sidelines in most
patent litigation.
Congress, as I indicated earlier, has had a number of hearings on patent reform
issues. 54 A bill has been dropped in the House of Representatives. 55 We may yet see
a bill coming up in the Senate. Thus far, legislative efforts are aligned fairly
accurately with recommendations from those four reports on the patent system. The
House bill aligns with many of the key recommendations of the Federal Trade

9 See Federal Trade Commission, To Promote Innovation: The ProperBalance of Competition
and PatentLaw and Poliey,Oct. 2003, http://www.ftc.gov/os/2OO3/1O/innovationrpt.pdf.
50 See Bruce Alberts, President, Nat'l Acad. of Scis., Address at the Academy's 141st Annual
Meeting:
A
World
that
Banks
on
Science
(Apr.
19,
2004),
available at
http ://www.nasonline.org/site/DocServer/2004address.pdf?doclD= 109.
51 The ABA Section of Intellectual Property Law, A Section White Paper: Agenda for 21st
Century
Patent
Reform
(revised
Sept.
16,
2005),
www.abanet.org/intelprop/home/PatentReformWP.pdf [hereinafter ABA White Paper].
52 See Letter from Gary Griswold, Past President of AIPLA, to Rep. Lamar Smith, Chairman,
H. Subcomm. on Courts, the Internet, and Intellectual Property (June 9, 2005),
http://www.aipla.org/Content/ContentGroups/Legislative-Action/109th-Congress/Testimony5/GGOr
alStatement.pdf.

S3 Id.

51See Overs-ightHearingon 'PatentHarmonization":HearingBefore the Subcomm. on Courts,
the Internet, and Intellectual Property of the H. Comm. on the Judiciary,109th Cong. (Apr. 27,
2006) (statement of Rep. Smith, Chairman, H. Subcomm. on Courts, the Internet, and Intellectual
Property) ("Today the subcommittee conducts its sixth hearing in the 109th Congress on patent
reform."),
available
at
http://judiciary.house.gov/OverSight.aspx?ID=235,
http://boss.streamos.com/real/hjudiciary/courts/courtsO42706.smi.
5 Patent Reform Act of 2005, H.R. 2795, 109th Cong. (2005) (as introduced June 8, 2005)
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Commission, 56 all the key recommendations of the National Academy of Sciences, 57
all the key recommendations in the ABA-IPL Section white paper, 58 and is very
consistent with what the American Intellectual Property Law Association sought to
have done with the patent system. 59 When Chairman Smith originally introduced
the House bill, there were a few industry-specific concerns. There was a provision on
compensatory damages that talked about limiting damages to the "inventive
60
contribution," raising concerns that this could codify "prior art subtraction".
Another provision in the House bill on injunctive relief that required a court to
consider the fairness in light of all facts and interests of relevant parties associated
with the invention. 61 Such language would be totally new to the patent statute and
would move the law some distance beyond the so-called "four factor test" for deciding
62
whether someone is entitled to an injunction.
From the pharmaceutical industry viewpoint the proposed injunction reform is
particularly problematic. A generic drug company might explain to a court that it is
going to give the patients a 25% discount on their generic version of an innovative
medicine if the court were to authorize them to engage in the ongoing infringement of
a valid patent. If a court were to decide that allowing the ongoing infringement was
a "fair" result to the innovator because the innovator had already made enough
money under the patent, a full 200 years of U.S. patent law principles would be
undone.
On July 26 of last year, Chairman Smith announced a substitute bill that many
hailed as making significant improvement. 63 First, the potential for "prior art
subtraction" was eliminated. 64 Second, the troublesome injunction provision was

56 Compare Patent Reform Act of 2005, H.R. 2795, 109th Cong. (2005) (as introduced June 8,
2005), with Federal Trade Commission Report, To Promote Innovation: The Proper Balance of
Competition
and
Patent
Law
and
Policy,
October
2003,
http ://www.ftc.gov/os/2003/10/innovationrpt.pdf.
57 Compare Patent Reform Act of 2005, H.R. 2795, 109th Cong. (2005) (as introduced June 8,
2005), with NAT'L ACAD. OF PUB. ADMIN. REPORT TO CONGRESS, U.S. PATENT AND TRADEMARK
OFFICE:
TRANSFORMING To MEET
THE
CHALLENGES
OF THE
211T CENTURY, (2005),

http://www.napawash.org/Pubs/PTO-8-25-05.htm.
58 Compare Patent Reform Act of 2005, H.R. 2795, 109th Cong. (2005) (as introduced June 8,
2005), with ABA White Paper, supra note 51
59 Compare Patent Reform Act of 2005, H.R. 2795, 109th Cong. (2005) (as introduced June 8,
2005), with PatentAct of2OO5.Hearingon H.R. 2795 Before Subcomm. on Courts, the Internet and
Intellectual Property of the Comm. on the H. Judiciary 109th Cong. (2005) (statement of Gary
Griswold, Past President of the American Intellectual Property Law Association).
60ABA White Paper, supra note 51, at 39.
61 ABA White Paper, supranote 51, at 45.
62 Univ. of Tex. v. Camenisch, 451 U.S. 390, 392 (U.S. 1981) (listing the following four factors
to be considered by federal courts when granting a preliminary injunction: "whether the plaintiff
will be irreparably harmed if the injunction does not issue; whether the defendant will be harmed if
the injunction does issue; whether the public interest will be served by the injunction; and whether
the plaintiff is likely to prevail on the merits.").
6 See Amendment in the Nature of a Substitute (proposed July 26, 2005),
http ://www.ipo.org/Template.cfm?Section=PatentReform 1&CONTENTID= 19482&TEMPLATE=/Co
ntentManagement/ContentDisplay.cfm
64See Id.; ei Patents Depend on Quality Act of 2006, H.R. 5096, 109th Cong. (2d Sess. 2006)
(omitting the section on combinational damages from the bill entirely).
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gone. 65 In response to the substitute, a coalition of about thirty companies banded
together and proposed basically that the Smith substitute bill be enacted, with some
relatively modest additional features added to the bill.66 Indeed, this so-called
coalition text from last September has now garnered support from the IPO, the
Intellectual Property Owners Association, 67 and the AIPLA.68
Except for some
relatively secondary issues, the coalition proposal aligns with the views in the white
69
paper of ABA-IPL section.
Several of the substitute bill's most significant features were supported by the
70
Business Software Alliance, which is clearly aligned with its IT-company members.
All but one key provision appeared to get some support from some elements of the
university community.7 1 A collection of academics, consisting of twenty-five law
school professors, got together and proposed some of these reforms and had some
reform ideas of their own.
These efforts aim for an objective patent system, a transparent patent system,
and one that can work more rapidly. In addition, the reform effort does squarely
tackle the issue of advancing civil justice for patent litigants. The coalition text and
the Smith substitute both would make changes in the manner in which venue in
patent cases would be administered.7 2 These changes are proposed with the idea that
65 See Amendment
in the Nature of a Substitute (proposed July 26, 2005),
http://www.ipo.org/Template.cfm?Section=Patent-Reform1&CONTENTID=19482&TEMPLATE=/Co
ntentManagement/ContentDisplay.cfm But see Patents Depend on Quality Act of 2006, H.R. 5096,
109th Cong. (2d Sess. 2006) (reintroducing the section on injunctions as originally proposed in the
bill of July 8, 2005).
66 See Letter from the Coalition for Patent Reform, to Hon. Lamar S. Smith, Chairman, H.
Subcommittee on the Courts, the Internet and Intellectual Property (Sept. 1, 2005),
http ://www.ipo.org/Template.cfm?Section=lome&CONTENTID=20145&TEMPLATE=/ContentMan
agement/ContentDisplay.cfm; see also AIPLA.org, A Coalition for 21st Century PatentLaw Reform.*
Balanced Initiatives to Advance Quality and Provide Litigation Reforms September 1, 2005,
http://www.aipla.org/Content/ContentGroups/LegislativeActionll09thCongress/House 1/CoalPrinto
fHR2795.pdt Intellectual Property Owners Association, Patent Reform: Comparison Chart on
Various
Bill
Versions
(revised
Apr.
6,
2006),
http://www.ipo.org/Template.cfm?Section=Patent-Reforml&CONTENTID=22028&TEMPLATE=/Co
ntentManagement/ContentDisplay.cfm (comparing the original H.R. 2795, the coalition's proposed
changes, and the newly proposed H.R. 5096).
67 See Patent Law Reform: PatentInjunctions and Damages:HearingBefore the S. Judiciary
Comm. on Intellectual Property, 109th Cong. (2005) (testimony of Jeffrey J. Hawley, President,
Intellectual Property Owners Association).
68 See PatentAct of2005: Hearingon H.R. 2795 Before Subcomm. on Courts, the Internet and
Intellectual Property of the Comm. on the H. Judiciary, 109th Cong. (2005) (statement of Gary
Griswold, Past President of the American Intellectual Property Law Association).
6 See ABA White Paper, supranote 51.
70 Amendment in the Nature ofA Substitute to HR. 2795, the PatentAct of2005: Hearingon
HR. 2795 Before Subcomm. on Courts, the Internet and IntellectualProperty of the Comm. on the
H. Judiciary, 109th Cong. (2005) (statement of Emery Simon, counselor to Business Software
Alliance) available at http ://www.bsa.org/usa/press/newsreleases/Testimony-Reform-Bill.cfm.
71 Before Subcomm. on Courts, the Internet and Intellectual Property of the Comm. on the H
Judiciarzy, 109th Cong. (2005) (statement of Charles E. Phelps, Provost, University of Rochester),
available at http.7/www.aau.eduintellect/PhelpsPatReTest7 26 05.pdf
72 Intellectual Property Owners Association, Patent Reform: Comparison Chart on Various Bill
Versions
(revised
Apr.
6,
2006),
http ://www.ipo.org/Template.cfm?Section=PatentReform 1&CONTENTID=22028&TEMPLATE=/Co
ntentManagement/ContentDisplay.cfm
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if neither the plaintiff nor the defendant has any particular connection, by evidence,
witnesses, or otherwise, to a particular venue, a court would be required to transfer
venue.
Punitive damages reforms that would eliminate willful infringement allegations
from essentially all patent litigation, was included. Another prime objective in the
civil justice system reform context was to have compensatory damages that
accurately codify Georgia-Pacificfactor thirteen, which mandates apportionment of
damages away from a patented invention when other contributions of economic value
are present, particularly when the infringing product is covered by a multiplicity of
73
patents that contribute value.
Pre-grant submissions of prior art and post-grant review of patents assure that,
as the patent is being examined and after the patent is being examined, the public
has the maximum opportunity to have an impact on the patenting process. The
publication of all applications at eighteen months also helps the patent system be
more fully transparent.
What would the patent system actually be like if either the Smith text or a
substitute of the coalition text became law? It would largely meet the twin goals of
transparency and objectiveness. The aforementioned goal would be largely met - if
you were a trained patent professional, and you were skilled in the technology of the
invention, you could actually pick up a patent or a published patent application,
review it, reference only publicly accessible information, and essentially make a final
and complete determination on every issue of patentability.7 4
In determining
validity, there would typically be no need to talk to the inventors about when they
did their work or what contemplations that had about the various modes of carrying
out the invention. 75 Invention dates would not be relevant for any purpose. 76 The
reforms would collectively produce an amazing transformation of the patent system,
just from the standpoint of required discovery to assess validity. This alone could
greatly moderate patent litigation costs. Since evidence related to the inventor's
state of mind and activities leading up to filing the patent would not be relevant to
validity, such evidence would not need to be discovered and these complicated and
subjective determinations would be erased from the law.
Under the Smith bill and the coalition-supported proposals, patents would
always be open to interpartespost-issuance revocation procedures. The key reform
creates a new post-grant opposition system. The public would be afforded a ninemonth window to challenge a patent immediately after issuance on any issue of
patent validity. If a questionable patent issued that should not have been issued,
that patent can be eliminated during the opposition.
A statutory requirement that the post-grant opposition be completed in one year,
would, by itself, work an amazing transformation of the manner in which the public
could participate in the administrative side of the patenting process.

Ga.-Pac. Corp. v. U.S. Plywood-Champion Papers, Inc., 318 F. Supp. 1116, 1120 (1970).
Patent Reform Act of 2005, H.R. 2795, 109th Cong. (2005).
75 Id. But see Patents Depend on Quality Act of 2006, H.R. 5096, 109th Cong. (2d Sess. 2006)
(eliminating the first-to-file provision among others).
76 See Patent Reform Act of 2005, H.R. 2795, 109th Cong. (2005). But see Patents Depend on
Quality Act of 2006, H.R. 5096, 109th Cong. (2d Sess. 2006) (eliminating the first-to-file provision
among others).
73

74 See
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Perhaps the keystone reform would offer the inventor an incentive to obtain a
fully valid patent. An inventor today, under the existing duty of candor and good
faith, 77 has no real incentive to obtain a wholly valid patent.78 The inventor has an
incentive to do two things in order to proactively defend against allegations of
inequitable conduct. First, there is the incentive to tell the Patent Office everything,
no matter how trivial its relationship to patent examination might seem. If a person
under the duty of candor withholds any information, no matter how seemingly
trivial, the withholding can be later alleged to have been material, permitting an
inference of intentionally deceptive conduct. 79 Second, there is an incentive to say
nothing that would be meaningful to the patent examiner in understanding the
invention and its relationship to the prior art. 80 Anything said about what any piece
of prior art might mean, or what the state of the art might be, can be used to
demonstrate that the inventor misrepresented the whole truth - there was
something more or something different that should have been said.81 Under today's
duty of candor and good faith, the practical incentive is to minimize the amount of
candor, not guide the patent examiner in any substantive way that might assure that
the patent examination is the most complete and most accurate that it can be.
The Smith substitute turns this state of affairs upside down. If a patent is fully
valid, it cannot be attacked as having been obtained through inequitable conduct.
The defense cannot be pled unless the accused infringer has already invalidated one
or more claims of the patent. This "valid patent safe harbor" from inequitable
conduct allegations will mean that the inventor has the opportunity to work with the
examiner and effectively say, "Let's make sure I get a valid patent."
In brief summary, Chairman Smith has identified three intertwined pillars of
patent reform. First are the transparency and objectiveness reforms. Second, are
the public participation reforms, the most sweeping of which is the post-grant
opposition proceeding in which the public can get the Patent Office to correct any
mistake made in issuing a patent. Third is the incentive to obtain a valid patent by
fixing the law of inequitable conduct.
In my view, it is the first and third pillars that make the second pillar both
possible and powerful. The transparency and objectiveness reforms make it possible
for all issues of patent validity to be efficiently decided by the Patent Office in the
post-grant opposition proceeding. Inequitable conduct reforms will mean better
quality examination, based upon true candor and good faith going both ways during
the original examination. This should reduce the number of oppositions by reducing
the number of questionably valid patents. This should make the burden on the
Patent Office of conducting post-grant oppositions more sustainable. In addition, it
means that patent owners will not face the specter of a huge increase in inequitable
conduct allegations based upon conduct during the post-grant opposition, at least
where the resulting patent is fully valid. Finally, the Smith substitute would enact
7737 C.F.R. § 1.56 (2006).
78Perspectives on Patents.:Hearing Before the S. Judiciary Comm. on Intellectual Property,
109th Cong. (2005) (testimony of Robert A. Armitage, Senior Vice President and General Counsel of
Eli
Lilly
and
Company),
available
at
http://judiciary.senate.gov/testimony.cfm?id=1475&wit-id=4230.
7937 C.F.R. § 1.56.
80 Jeffrey G. Sheldon, How to Write a PatentApplication, at § 7, § 7.5.7.2 (PLI,2005)
81Id.
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the third pillar reforms by placing the opposer under a duty of candor and good faith,
which is needed to provide protection during the opposition against opposer
misconduct that might otherwise result in wrongful cancellation of patent claims.
It remains possible, but far from certain, that what today appears as a great
patent divide between those seeking radical reform of the patent laws and those
desiring to leave the effectiveness of the patent system untouched can be bridged.
However, assuming that it can be bridged, what ought to be done after Chairman
Smith's three pillars become law?
While the three pillars would afford
comprehensive reform, one of the most important problems the patent system faces
today is left untouched: the nineteenth-century paradigm for patent examination.
Why do we have a patent office that is a real place, a billion-dollar edifice in
Alexandria, Virginia? For those of us of a certain age, we actually remember why we
have a physical patent office. A physical patent office was established because that
is where the paper was kept. Millions of pieces of paper were housed so that prior art
could be searched. Those documents were organized and classified so examiners and
the patent professions could search the prior art efficiently. Without a physical
patent office, there was no feasible way in which to conduct a high-quality patent
examination.
When patent examination itself was first created, the patent shoes were
designed for manual searching by human hands in order to find relevant prior art.
Only after fingering through the patent shoes, looking mostly at patent drawings,
82
could the patent examiner determine whether an invention was patentable.
In the Age of Google, this does seem a bit quaint. What is clear, however, is that
the Patent Office no longer has a monopoly on the information needed to examine.
Indeed, it is not just that the monopoly is gone, the relevance of a patent office as a
physical place for housing and accessing the information needed for patent
examination has all but vanished. The premise of the a patent office, built on the
paradigm of shoes containing issued patents to be searched, if not vanished now, will
be in five to ten years
The Patent Office today does have a monopoly or even primacy on the
information that's needed to examine; that information is globally accessible.8 3 As
noted earlier, the job of the patent examiner is further complicated by the fact that
inventions are more complicated; the underlying technology on which they are based
is complicated.8 4 More people are patenting more things,8 5 especially in high

82 See KENNETH W. DOBYNS, THE PATENT OFFICE PONY: A HISTORY OF THE EARLY PATENT
OFFICE 193 (Sergeant Kirkland's Press 1994), available athttp://www.myoutbox.net/popch3l.htm.
83 See Google, www.google.com (last visited Apr. 19, 2006); Yahoo!, www.yahoo.com (last
visited Apr. 19, 2006); United States Patent and Trademark Office Homepage, http://www.uspto.gov/
(last visited Apr. 19, 2006).
84 Dan Ness, Eloetronis Still Widely Soon As Too Complieatod, but Paorents Tend to Be More
Philosophical,Oct. 18, 2004, http://www.technologyuser.com/pages/info/tup-dates/tupan04-dO6.htm
("Consumer electronic products are more complicated than they ought to be, according to fully a
quarter of the American population.").
85 Office of Electronic Information Products Patent Technology Monitoring Division (PTMD),
U.S. Patent & Trademark Office, U.S. Patent Statistics Chart Calendar Years 1963-2004,
http://www.uspto.gov/web/offices/ac/ido/oeip/taf/us stat.htm (last visited Apr. 18, 2006) (noting an
increase in the number of patents issued from 48,971 in 1963 to 181,302 in 2004).
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technology areas, where more patents are connected to one another and what is
86
patented is an aspect of a complex, multi-technology system.
Patents today are more consequential. There are vastly greater consequences
today for getting the patent process wrong and failing to obtain a valid patent or for
misjudging whether a competitor has succeeded or failed in obtaining valid patent
protection.
So if we fast forward from the halcyon days of the nineteenth century to the IPsupercharged twenty-first century and ask, "What do patent examiners need in the
twenty-first century to effectively examine patent applications?," the answer is very
clear. They have little need for access to mounds of paper to be housed in classified
patent shoes. They need legal training and experience in applying that training to
complex technologies.
They need a thorough understanding of patentability
requirements and their application. They need technical expertise in the field of the
invention - or someone to guide them through the patent application in a manner to
assist in acquiring that expertise. They need continuity from the beginning to the
end of the process - and they need that process to run from start to finish in a
reasonable time period. They need sufficient time - and the amount of time they
need is dependent upon the amount of guidance they can get to learn and synthesize
what they need to know. They need sufficient time to understand today's more
complicated patent applications. They need to digest what is really being claimed
and the pertinence of the prior art.
One way of looking at what patent examiners need is that it is everything that is
in short supply in the Patent Office, and exactly what most inventors and their
patent counsel have in much greater abundance. In many respects, the change in
the way the world of invention works means that a complete reversal of roles has
transpired. Back in the old, twentieth-century days, it used to be that you'd actually
go talk to a patent examiner to learn about the prior art and to understand the field
of technology. The examiner could guide an applicant to the closest prior art.
So what should this near role-reversal mean in the future? It can only mean one
thing, if patent quality is to be enhanced: increased applicant responsibility. This is
a term Director Dudas used in his April 2005 Senate testimony on patent system
reform.87 He is working to push this concept forward through a PTO proposed rule
package on claiming and continuation application practices.8 8
Director Dudas

86 See FISCAL YEAR 1998 USPTO ANNUAL REPORT: A PATENT AND TRADEMARK OFFICE REVIEW:
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available
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http://www.uspto.gov/web/offices/com/annual/1998/a98r-2.htm (noting that the largest increase in
patent applications come from high technology areas).
87 The Patent System:
Today and Tomorrow. Hearing Before Subcomm. on Intellectual
Property of the S. Comm. on the Judiciary,109th Cong. 10 (Apr. 21, 2005) (Statement of Jon W.

Dudas, Under Secretary of Commerce for Intellectual Property and Director of the United States
Patent
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Office),
available
at
http://www.uspto.gov/web/offices/com/speeches/2005apr21.pdf.
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http://www.uspto.gov/web/offices/com/sol/notices/71fr61.pdf.
The Office is also proposing that if an application contains more than ten
independent claims (a rare occurrence), or if the applicant wishes to have initial
examination of more than ten representative claims, then the applicant must
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proposes that an inventor submitting more than a nominal number of claims must
89
provide the patent examiner with a new "examination support document.
The examination support document will require that the inventor have done a
search of the prior art. 90 The support document will include an information
disclosure statement in which the inventor will be obliged to take the most pertinent
prior art and apply it to the claims, so it's clear how the invention and the claims
relate. 91 The inventor will need to set out the basis on which the invention can be
regarded useful, why section 112 support exists in the patent application for the
claims, and the underlying basis for patentability over the prior art.
The reception that these proposed rules have received has been far short of an
embrace. Resistance to these proposals for inventors forced to operate under today's
patent law is unsurprising.
The leadership of the Patent Office has made the
calculation, driven by its patent application pendency problems, to force patent
applicants to file fewer claims in patent applications. Since under today's patent
laws, no inventor is about to file an examination support document, the Patent Office
calculation is undoubtedly accurate.
What would the situation for inventors be if the three-pillar patent reforms
became law, most especially the incentive to obtain a wholly valid patent by
providing a safe harbor for fully valid patents against any and all inequitable conduct
charges? I would submit that under those conditions, the "examination support
document" could and should be made the central feature of all patent examination.
In other words, Director Dudas has described the precise tool that is needed for
inventors to be able to guide patent examiners through the patent examination
process in what should be the paradigm for twenty-first century patent examination
look like.
Allow me to move to the concluding portion of this lecture by providing one
possible vision for twenty-first century patent examination on the premise that the
three-pillar reforms become law. The paradigm could incorporate several new
principles.
First of all, the Patent Office should adopt a new mantra for examination: "If
you (the inventor) come, they (the Patent Office) will build it. In other words,
inventors are always free to come to the Patent Office, present their claims in
whatever number or form they desire, and inventors can rest assured that the patent
examiners will examine them. The thrust of the new paradigm is antithetical to
attempts to limit the workload of the Office by barring the door to an inventor. It is
simply and always the inventor's prerogative to define what abundance of claims to
protect an invention is needed and the role of the Patent Office to allow the inventor
to seek that abundance of claims to protect an invention. As a critical corollary, the
provide an examination support document that covers all of the independent
claims and the dependent claims designated for initial examination.

Id.
89Id.
90
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Patent Office must stop restriction practice. It is a means of deferring examination of
claims, needlessly relieving both the inventor and the Patent Office of their
responsibility to reach a full and final determination of what in the patent
92
application will mature into enforceable rights.
Once a patent application publishes at eighteen months, the next principle is to
oblige the inventor to file an examination support document for each claim in the
application. The model for this statement is precisely what Director Dudas proposed
in January of this year and that, under the current "inequitable conduct" law, patent
practitioner or inventor today is prepared to do.
Why - once a "valid patent safe harbor" becomes law - should the inventor have
the affirmative burden of guiding the patent examiner through the invention and its
basis for patentability? Among the several reasons are the tremendous acceleration
of the patent examination process, the potential for a higher quality work product by
a fully briefed patent examiner, and the decreased likelihood that a successful postgrant challenge to the patent will be needed, much less successful. If inventors
expect that patents should have the full attributes of property rights, then the
greater certainty in the scope of the valid rights and the greater speed in their
establishment are essential predicates. Greater applicant responsibility is the key to
preserving the twenty-first century patent system as a property-rights system.
A third principle is further needed to cement the property-rights character of the
twenty-first century patent system. Once a patent application has been published,
Congress should eliminate all continuing applications for patent, most especially the
so-called "continuation-in-part applications" in which new disclosure and broader
claims may be introduced. The last decade has seen an explosive growth in the filing
of continuing applications by a small subset of inventors and practitioners.
The
practice has become the opiate of the patent profession, or at least some subset of it.
Director Dudas has heard the arguments that inventors cannot live without these
applications or that, if a small dose of continuing application practice is permitted,
the addiction can be kept in control.
It is not unknown for inventors today to file more than a dozen continuing
applications and to issue patent after patent based on a single original patent filing.
The process of continuing and patenting and continuing and patenting can continue
until the 20-year patent term is finally exhausted. The entire 20-year patent term
can be consumed before the public has a full and final understanding of what can be
patented based upon that single, original patent filing. This is not how the patent
system was ever intended to work.
A fourth principle is for Congress to get rid of the notion that patents have to be
granted unless the patent examiner can demonstrate that the requirements for
patentability have not been met. This should be done by increasing patent examiner
accountability in exactly the same manner that there is increased applicant
responsibility.
Patent examiners should be obligated to produce, as the patent
examination work product, a "summary basis of patentability" document. Upon
reading the document, the public should have an understanding of why a patent was
issued on each of the patent claims that issued. This patent examiner work product
can be built from the inventor's examination support document - in other words,
92 U.S. PAT. & TRADEMARK OFFICE, U.S. DEP'T OF COMMERCE, MANUAL OF PATENT EXAMINING

PROCEDURE § 802.02 (8th ed., 2nd rev. 2004).
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patent examination becomes more of a partnership in which patent professionals will
guide patent examiners through key aspects of the determination of patentability.
If these changes are made, a fifth principle is to dispense with the adversarial
language that is used by patent examiners today. Inventions are no longer
patentable unless the patent examiner finds a reason to reject claims; inventions are
awarded patents only when patent examiners identify sufficient reasons to permit
patents to issue. Patent examiners would no longer need to "reject" claims in patent
applications because claims would no longer be presumptive patentable. Instead
patent examiners could focus on whether a sufficient basis for issuing the patent had
yet been established.
If these principles were to be part of a next-generation of patent reform, what
would it mean for the patent profession and for the public? First, today there are
some patents where the examination record is very thin and the relevance or
significance of the patented technology is unclear. Such situations would rarely
exist, if they would exist at all, if both patent applicants and patent examiners had
these increased responsibilities.
Because public would more rapidly understand the significance of patented
inventions and the basis for their patentability, the number of questionable patents
would decline and, hopefully, post-grant oppositions would be fewer. In addition, the
fuller and clearer prosecution record will assist the public to understand the true
metes and bounds of a patented invention, further reducing the patents in which a
post-grant opposition might be sought to clarify a patent's reach.
On the Patent Office website is a graph that demonstrates what might happen
to the patent examination system if we do nothing to the existing patent examination
paradigm. Between now and 2010, it projects an exponential decay in the ability of
the Patent Office to issue patents promptly. In some technology fields, patents won't
issue for fifty months to one-hundred months after a patent is sought. At this point,
the resulting system is effectively non-functional. The Patent Office does project that
by changing the patent examination paradigm, future patent pendency figures would
radically differ, plummeting to a few months. According to the Patent Office data,
the key change needed to work this near-miracle is instituting examination support
documents across the board. This solution is more effective and more sustainable
that the ongoing efforts at hiring one-thousand new patent examiners a year for the
indefinite future. This solution is far better than limiting the ability of inventors to
having all their presented claims examined.
Where are we today in this great adventure at reforming the patent laws?
Congress is today taking a close look at making truly historic changes. 93 A number of
impressive studies of the patent system conclude that patent reforms should include
quite radical reforms. However, the needed reforms must focus on the root causes for
dissatisfaction with patent quality and civil justice for patent litigants. Going after
root causes of dissatisfaction should allow us to leave the effectiveness of the patent
system as an incentive to create innovation untouched. It should further set the
stage for us to move to a new, twenty-first century paradigm for the examination of
patents that would increase both the responsibility of patent applicants and the
accountability of patent examiners. Only when all these elements of reform have
come together should we be satisfied that we have created a patent system fully
9 Patent Reform Act of 2005, H.R. 2795, 109th Cong. (2005).
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meeting the needs of inventors for securing valuable property rights, as well as the
demands of the public for a patent system that produces quality patents and permits
them to be challenged and enforced under rules affording civil justice for all patent
litigants.

